Riskpilot← Back to searchSign inGet full accessCAEDO ONCOLOGY AS
ASActiveOrg 926135082Gaustadalléen 21, 0349 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20205 employees
Revenue 2024
NOK 0
EBITDA margin
—
+68% vs 2023
Equity ratio
67.1%
Financial strength
Net profit 2024
NOK -3,6M
+68% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -3,5M | +68% |
| Net profit | NOK -3,6M | +68% |
| Total assets | NOK 42,6M | +162% |
| Equity | NOK 28,6M | +98% |
| Employees | 5 | — |
Legal name
CAEDO ONCOLOGY AS
Org number
926135082
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. desember 2020
Share capital
NOK 165 113
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Utvikle, markedsføre og selge medisinske produkter og utstyr samt det som står i forbindelse med dette.
Address
Gaustadalléen 21, 0349 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −238 | −1 297 | −2 091 | −605 |
| EBITDA | 0 | −3 156 | −8 386 | −11 012 | −3 492 |
| Depreciation & amort. | −0 | −0 | −26 | −175 | −183 |
| EBIT | 0 | −3 156 | −8 412 | −11 187 | −3 675 |
| Net financials | 0 | −7 | −111 | 10 | 65 |
| Profit before tax | 0 | −3 163 | −8 523 | −11 177 | −3 610 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −3 163 | −8 523 | −11 177 | −3 610 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 226 | 1 561 | 11 509 | 16 253 | 42 573 |
| Equity | 4 185 | 1 023 | 10 278 | 14 417 | 28 582 |
| Long-term debt | 0 | 0 | 278 | 0 | 5 835 |
| Short-term debt | 40 | 539 | 953 | 1 836 | 1 525 |
| Total debt | 40 | 539 | 1 231 | 1 836 | 7 360 |
EBITDA margin
-349185800.0%
This company
15.8%
Market median
-2210036809% vs market
20202024
Equity ratio
67.1%
This company
38.2%
Market median
+76% vs market
20202024
Return on equity
-12.6%
This company
18.4%
Market median
-168% vs market
20202024
Net profit margin
-360978700.0%
This company
8.1%
Market median
-4456527260% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40.29% | 40.29% | 2024 | |
| Company | 19.15% | 19.15% | 2024 | |
| Company | 13.63% | 13.63% | 2024 | |
| Company | 11.01% | 11.01% | 2024 | |
| Company | 3.83% | 3.83% | 2024 | |
| Company | 3.83% | 3.83% | 2024 | |
| Individual | 2.72% | 2.72% | 2022 | |
| Company | 2.64% | 2.64% | 2024 | |
| Company | 1.92% | 1.92% | 2024 | |
| Individual | 1.46% | 1.46% | 2024 | |
| Company | 1.26% | 1.26% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
P Invest Norge As
CAEDO ONCOLOGY AS Board members of CAEDO ONCOLOGY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Hestdal | Chief Executive Officer | 0 companies |
| Jens-Otto Forbergskog | Board of Directors | 0 companies |
| Rolf Dagfinn Pettersen | Board of Directors | 0 companies |
| Ole Jesper Dahlberg | Board of Directors | 0 companies |
| Erlend Petter Skagseth | Chairman | 0 companies |